Following adults with advanced chronic liver disease to learn what leads to liver problems
Follows adults with advanced chronic liver disease for 10 years, with yearly liver scans.
Key facts
- Who runs it
- Chinese University of Hong Kong
- Where
- Hong Kong1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Natural History of Advanced Chronic Liver Diseases
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 25 Sept 2024
- Expected to end
- Dec 2035
- Type of study
- Observational
- Treatments tested
- Transient elastography
- Record updated
- 20 October 2026
Who can take part
The trial is looking for adults with advanced chronic liver disease (ACLD), including cirrhosis (scarring of the liver). Participants are followed for 10 years and have a yearly liver stiffness scan.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Advanced chronic liver disease. This means a liver stiffness result (LSM) above 10kPa, or signs of cirrhosis. Cirrhosis signs are a scarred liver and high pressure in the liver veins on ultrasound, or swollen veins in the food pipe or stomach seen on a camera test (OGD).
- Earlier treatment
- People who have had a liver transplant cannot join.
- Biomarker or test result
- Liver stiffness measurement (LSM) above 10kPa, or cirrhosis signs on ultrasound or OGD.
- Main reasons for not taking part
- Liver cancer (hepatocellular carcinoma, HCC) now or in the past
- Past liver transplant
- No spleen, or spleen removed by surgery
- Serious illness with expected life span under 6 months
- Pregnancy
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Aged 18 or above
- Known ACLD, defined by:; LSM > 10kPa or; Clinical cirrhosis, suggested by 1. ultrasonography of the hepatobiliary system shows features of cirrhosis (e.g. shrunken and nodular liver) and portal hypertension (e.g. dilated portal vein, portal-systemic collaterals or varices, splenomegaly, ascites). 2. Oesophagogastroduodenoscopy (OGD) shows presence of oesophageal varices (OV) and/or gastric varices (GV) and/or portal hypertensive gastropathy
Who cannot take part
- Current or past history of hepatocellular carcinoma (HCC)
- History of liver transplantation
- Asplenism or history of splenectomy
- Serious medical illness with limited life expectancy of less than 6 months
- Pregnancy
- Unable to obtain or refusal of informed consent from patient
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Cirrhosis or advanced chronic liver disease
This trial is currently available in Hong Kong.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a retrospective-prospective registry cohort study. Patients with advanced chronic liver disease (ACLD) will be prospectively invited to this study. The study follow-up duration will be 10 years. The primary outcome is incident hepatic events and liver-related mortality. Participants will undergo annual transient elastography examination.
The group in the trial
- Patients with advanced chronic liver disease
Adult patients with advanced chronic liver disease
Treatment: Transient elastography
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Natural History of Advanced Chronic Liver Diseases and Factors Associated With Hepatic Events - a Registry Study
- Plain-language title
- Following adults with advanced chronic liver disease to learn what leads to liver problemsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07042308, who can take part
- Record updated
- 20 October 2026